All In Biotech

Drug Trial Radar · NCT02733185

Trial to Assess Chelation Therapy 2

Last checked: Nov 19, 2026Latest source record: Mar 30, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,000 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,000

Actual

Start

Oct 1, 2016

Primary completion

Jun 30, 2023

Study completion Jun 30, 2023

Sponsor

Lead sponsor
Mt. Sinai Medical Center, MiamiAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Center for Complementary and Integrative Health (NCCIH); National Heart, Lung, and Blood Institute (NHLBI); Duke Clinical Research Institute
First posted
Apr 11, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Factorial
Masking
Triple (participant, care provider, investigator)
Primary purpose
Prevention
FDA-regulated drug
Yes
Who can join
All sexes, from 50 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Trial to Assess Chelation Therapy 2 (TACT2) is a randomized, double blind controlled factorial clinical trial of edetate disodium-based chelation and high-dose oral vitamins and minerals to prevent recurrent cardiac events in diabetic patients with a prior myocardial infarction (MI).

Conditions

  • Diabetes
  • Myocardial Infarction

Interventions

  • disodium EDTADrug

    IV Disodium Ethylene diamine tetra acetic acid in 500 cc

  • Oral Multi Vitamins/Minerals (OMVM)Dietary supplement

    6 tablets of Multi-vitamin/Multimineral daily

  • Placebo disodium EDTADrug

    IV Placebo comparator- 500 normal saline

  • Placebo Oral Multi Vitamins/Minerals (OMVM)Dietary supplement

    6 tablets of a placebo Multi-vitamin/Multimineral daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Primary Composite OutcomeTime frame: 48 month follow-up (median)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Mount Sinai Medical Center

    Miami Beach, Florida

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.